Protocol Ledger

NCT03621280 · Phase III · COMPLETED

Open-label Treatment in Cushing's Syndrome

Interventional Phase III clinical trial protocol NCT03621280 sponsored by Cortendo in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-01-07 Enrollment: 51 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03621280
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)51 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03621280
Protocol FieldVerified Registry Value
NCT IdentifierNCT03621280
Consolidated Lead SponsorCortendo
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment51 participants (ACTUAL)
Registered Start Date2019-01-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI